Month: August 2021

HAUPPAUGE, N.Y., Aug. 27, 2021 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced its launch of commercial distribution of an FDA Emergency Use Authorized, patent pending, rapid point-of-care COVID-19 antigen test for use in decentralized and traditional testing settings. Product inventory is on-hand and immediately available for shipment to Chembio customers across the United States. The SCoV-2 Ag Detect™ Rapid Test, manufactured by InBios International, Inc., is a rapid immunoassay test authorized for use in laboratories with a CLIA waiver certification. It provides results in 20 minutes from a nasal swab and requires no instrumentation. The test can be used for both patients who are suspected of COVID-19 by their healthcare...

VANCOUVER, British Columbia, Aug. 27, 2021 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG”), a vertically integrated blockchain and cryptocurrency technology company, today announces that it will host a conference call to review third quarter 2021 financial results and provide a corporate update Wednesday, September 1, 2021, at 5:00 pm ET. DMG’s financials will be released after the market closes on August 30th. Participants are asked to pre-register for the call through the following link: https://dpregister.com/sreg/10159913/ecc6b990ae. Please note that registered participants will receive their dial in number upon registration and will dial directly into the call without delay. Those without Internet access or unable to pre-register may dial in by calling: 1-833-953-2438...

Sydney, Aug. 27, 2021 (GLOBE NEWSWIRE) — SYDNEY, AUSTRALIA – 27 August 2021 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), is pleased to announce the grant of patent no. ZL201580013695.X entitled “Antibody molecules to LAG-3 and uses thereof” by the Chinese Patent Office. This new Chinese patent follows the grant of the corresponding Australian, United States, European, and Japanese patents announced in 2018 through 2020. In particular, the claims of the patent are directed to LAG525, pharmaceutical compositions comprising LAG525, nucleic acid molecules that code for the LAG525 antibody, an expression vector or host cell that comprises the nucleic acid molecules, and to the use of LAG525 in the manufacture of a preparation for the treatment of cancer or infectious disease. LAG525 (INN: leramilimab)...

SHENZHEN, Aug. 27, 2021 (GLOBE NEWSWIRE) — Taoping Inc. (NASDAQ: TAOP, the “Company” or “TAOP”), a provider of blockchain technology and smart cloud services, today announces that its wholly-owned subsidiary Taoping Digital Assets (Asia) Limited (“TDAA”) and a Kazakhstan company Aral Petroleum Capital LLP (“APC”) have signed a memorandum of understanding (“MOU”) to establish a joint venture in Kazakhstan, of which TDAA and APC will own 51% and 49%, respectively. TDAA will control the board of directors of the joint venture. APC is an oil and gas exploration and development company operating in Kazakhstan, a wholly-owned subsidiary of Caspian Energy Inc. It holds an exclusive license which entitles it to explore and develop certain oil and gas properties known as the “North Block”, an area of...

New York, Aug. 27, 2021 (GLOBE NEWSWIRE) — (GTII: OTCQB) Global Tech Industries Group, Inc. (“GTII” or “the Company”), www.gtii-us.com, a Nevada Corporation, announced today that it has been informed by the SEC that its registration statement on Form S-1, registering the shares of common stock underlying the Company’s recently distributed warrants, has been declared effective. Therefore, all shares underlying such warrants are registered for resale following exercise. Furthermore, the Company’s trading platform, BeyondBlockchain.us, added several crypto currencies to its roster of currencies that are available for its users to trade, which are also featured on the newly-released mobile app. Finally, the Company’s board of directors has authorized management to continue its efforts at retiring long-term debt, which has already been...

Initial findings from an ongoing study demonstrated that a 0.3 mg/kg dose of ALRN-6924 has been very well tolerated and resulted in p53-mediated induction of the cell cycle inhibitor p21 in normal bone marrow cells in healthy volunteers Aileron is currently conducting a Phase 1b randomized, double-blind, placebo-controlled trial of ALRN-6924 0.3 mg/kg as a chemoprotective agent in patients with advanced p53-mutated non-small cell lung cancer (NSCLC) ALRN-6924 is designed to activate normal p53 in healthy cells, thereby upregulating p21, which selectively pauses cell cycle in normal cells but not in cancer cells with mutant p53 Nearly 1 million patients in the U.S., across all cancer types, are diagnosed annually with p53-mutated cancerBOSTON, Aug. 27, 2021 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection...

BOSTON, Aug. 27, 2021 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) today announced its daily fantasy sports product is set to go live in Arizona on Saturday, August 28, pending regulatory approval, which would make Arizona the 44th state to offer DraftKings Daily Fantasy Sports. DraftKings offers several contests for professional, collegiate and international leagues and supports the broadest selection of sports categories in the industry including popular NFL, NBA and MLB contests and other fan favorites that Arizona customers, 21 and over, will be able to experience for the first time ever. “There is no better time of the year to launch our leading daily fantasy sports app than ahead of the NFL season,” said Matt Kalish, co-founder and president of DraftKings North America. “We’re excited for the opportunity to provide Arizona...